Université de Sherbrooke at ASHG 2026
Oct 20–24, 2026 Montréal, Canada ~7.5k attendees Website
Université de Sherbrooke brings 7 presentations from 4 research groups to ASHG 2026 in Montréal. Its program at this meeting centres on rare diseases, genomic screening, and genetics-guided treatment. Équipe du Pr Bouchard expands carrier screening across three Québec regions, Choquet Lab decodes COL6A1-3 splicing in muscular dystrophies, and Laboratoire de recherche et transfert en pharmacogénétique (LRTP) investigates variants for advanced ulcerative colitis therapies.
| Organization | ASHG 2026 Attendance |
|---|---|
Université de Sherbrooke Sherbrooke, Quebec | 5 PhD Students |
Équipe du Pr Bouchardchairegps.com Studies blood microRNAs, 850,000-site DNA-methylation arrays and genetic carrier-screening samples. Projects target gestational diabetes, childhood obesity and rare founder-effect diseases in Québec populations.
| Poster Wed Oct 21 2:30 pm Microtranscriptomic response to oral glucose load in parous women with and without prior history of gestational diabetes DiabetesEpigeneticsMicroRNAWomen's health Poster Wed Oct 21 2:30 pm Expansion of the provincial carrier screening program for populations from Saguenay-Lac-Saint-Jean, Charlevoix, and Haute-Côte-Nord Regions (Québec, Canada) Rare variantsGenetic testingPublic healthClinical genetics |
Choquet Labchoquetlab.com Studies RNA maturation using nanopore direct RNA sequencing, functional genomics, molecular biology and bioinformatics. Focuses on long-transcript splicing, cell differentiation and human disease.
| Poster Wed Oct 21 2:30 pm Decoding the Splicing Order of COL6A1-3: A Key to Understanding Collagen VI-Related Muscular Dystrophies Alternative splicingSplicing mechanismsGenetic variationMuscular abnormalities |
Laboratoire de recherche et transfert en pharmacogénétique (LRTP)lrtp.ca Develops genetic tests from biological samples using digital PCR. Studies medication response in inflammatory bowel disease, diabetes and MODY2.
| Poster Thu Oct 22 4:15 pm Pharmacogenetic variants investigation for advanced therapies in ulcerative colitis treatment PharmacogenomicsCandidate geneGastrointestinal systemMolecular therapeutics |
Équipe de recherche sur les pratiques professionnelles optimales en soins primaires (PPOSP)en.poitraslab.com/equipederecherche Studies patient-reported data (PREMs and PROMs) and MODY2 genetic-testing implementation in primary care. Improves patient-centered practices through knowledge transfer and Canadian research partnerships.
| Poster Wed Oct 21 2:30 pm Evaluation of the Implementation of Genetic Testing for MODY2 Screening in Primary Care in the Saguenay–Lac-Saint-Jean Region: Pilot Phase of the iMOgene Project Genetic testingDiabetesDiagnosticsPrecision medicine |
| 2 more presenters — research group not yet identified | |
Instantly find 20 buyers from Université de Sherbrooke
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Human Genetics. Submit a correction